Conference Call Scheduled for July 21, 2016 at 11:00 am EASTERN DUBLIN, Ireland, July 14, 2016 -- Trinity Biotech plc (Nasdaq:TRIB), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory markets, will report...
Trinity Biotech Announces Results for Q1, 2016
DUBLIN, April 19, 2016 -- Trinity Biotech plc (Nasdaq:TRIB), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory markets, today announced results for the quarter ended March 31, 2016. Quarter 1 Results Total...
Trinity Biotech plc to Announce First Quarter Fiscal Year 2016 Financial Results
Conference Call Scheduled for April 19, 2016 at 11:00 am EASTERN DUBLIN, April 15, 2016 -- Trinity Biotech plc (Nasdaq:TRIB), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory markets, will report financial...
Trinity Biotech Announces Results for Q4 and Fiscal Year 2015
Annual Dividend Suspended, Share Buyback Program Announced DUBLIN, March 03, 2016 -- Trinity Biotech plc (Nasdaq:TRIB), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory markets, today announced results for...
Trinity Biotech plc to Announce Fourth Quarter and Fiscal Year 2015 Financial Results
Conference Call Scheduled for March 3, 2016 at 11:00 am EASTERN DUBLIN , Feb. 26, 2016 -- Trinity Biotech plc (Nasdaq:TRIB), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory markets, will report financial...